Ripple kopen? Dit zijn de mogelijkheden

Fisher & Paykel Healthcare Aandeel

<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Taxaties voor Fisher & Paykel Healthcare

KPI 2019 2020e 2021e 2022e 2023e
Dividend 0,23 0,27 0,32 0,37 0,44
Dividendrendement (in %) - 1,62 1,89 2,21 2,64
K/W-verhouding - 38,87 34,03 29,90 26,53
Winst/Aandeel 0,36 0,43 0,49 0,56 0,63

Nieuws voor Fisher & Paykel Healthcare Corporation LtdShs

Geen nieuws beschikbaar
Meer nieuws

Analisten over Fisher & Paykel Healthcare Corporation LtdShs

meer analisten

Fisher & Paykel Healthcare Peer Group

pagehit

Invoer toevoegen

Wat denkt u?

Profiel Fisher & Paykel Healthcare Corporation LtdShsnaar bedrijfsprofiel

Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following segments: The New Zealand, North America, Europe, and Asia-Pacific. New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. The North America segment refers to all activities controlled by entities or employees based in the United States of America and Canada, principally sales, distribution and administration activities. The Europe segment includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, principally sales, distribution and administration activities. The Asia-Pacific segment refers to all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, principally sales, distribution and administration activities. The company was founded in 1934 and is headquartered in Auckland, New Zealand.

Realtime koers Fisher & Paykel Healthcare Corporation LtdShs

Bid
10,60 
EUR
Ask
11,20 
EUR
Tijd
08:04 
Beurs STU

Naar aandeel Fisher & Paykel Healthcare

ISIN NZFAPE0001S2
Indices Australia All Ordinaries

Fisher & Paykel Healthcare Kerncijfers

Marktkapitalisatie in Euro 5,86 Mrd
Vrij verhandelbaar in %
Aantal Aandelen 574,32
Kasstroom/Aandeel in lokale valuta 0,44
Boekwaarde/Aandeel in lokale valuta 1,59
60 Dagen Volatiliteit 31,67
K/B verhouding